Ivax, Forest Square Off Over Antidepressant Drug
Firing the opening shot at trial, generic drug maker Ivax Corp. vigorously defended its alleged infringement of the antidepressant Lexapro, asserting that Forest Laboratories' patent for the blockbuster drug is invalid....To view the full article, register now.
Already a subscriber? Click here to view full article